[1]
“Disrupted Immune Balance in Graves’ Disease: Evaluation of IL-35, CXCL10, and IL-4”, AIMCJ, vol. 3, no. 2, pp. 84–90, Aug. 2026, doi: 10.58564/AIMCJ3.2.2026.275.